Evidence map›Paper›PMID 40621901›Full record

ArticleThe FEBS journal2025

A somatic multiple myeloma mutation unravels a mechanism of oligomerization-mediated product inhibition in GGPPS.

Ruba Yehia, Jasmína Mária Portašiková, Rut Mor Yosef, Benny Da'adoosh, Alan Kádek, Petr Man, Moshe Giladi, Yoni Haitin

Abstract read
In one paragraph

Article in The FEBS journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Ruba YehiaDepartment of Physiology and Pharmacology, Gray Faculty of Medical and Health Sciences, Tel-Aviv University, Israel.
Jasmína Mária PortašikováDivision BioCeV, Institute of Microbiology of the Czech Academy of Sciences, Vestec, Czech Republic.
Rut Mor YosefDepartment of Physiology and Pharmacology, Gray Faculty of Medical and Health Sciences, Tel-Aviv University, Israel.
Benny Da'adooshBLAVATNIK CENTER for Drug Discovery, Tel Aviv University, Israel.
Alan KádekDivision BioCeV, Institute of Microbiology of the Czech Academy of Sciences, Vestec, Czech Republic.ORCID https://orcid.org/0000-0002-7953-5870
Petr ManDivision BioCeV, Institute of Microbiology of the Czech Academy of Sciences, Vestec, Czech Republic.
Moshe GiladiDepartment of Physiology and Pharmacology, Gray Faculty of Medical and Health Sciences, Tel-Aviv University, Israel.ORCID https://orcid.org/0000-0002-8589-6920
Yoni HaitinDepartment of Physiology and Pharmacology, Gray Faculty of Medical and Health Sciences, Tel-Aviv University, Israel.ORCID https://orcid.org/0000-0002-1648-6792

Funding

Israel Cancer Association 20230029Israel Cancer Research Fund 1289067Israel Cancer Research Fund 19202Israel Science Foundation 1653/21Ministerstvo Školství, Mládeže a Tělovýchovy CZ.02.01.01/00/22_008/0004624United States-Israel Binational Science Foundation 2023190
6 · The paper itself

Abstract

Protein prenylation plays a critical role in regulating the cellular localization of small GTPases and is essential for multiple myeloma (MM) pathology. Geranylgeranyl diphosphate synthase (GGPPS), producing a key prenylation moiety, exists in a dimeric or hexameric form, depending on the species. However, the functional significance of this oligomerization remains unclear. Using crystallography, mass spectrometry, and fluorescence spectroscopy, we show that the GGPPS

Indexed as

FarnesyltranstransferaseMultiple MyelomaMutationCatalytic DomainCell Line, TumorCrystallography, X-RayHumansModels, MolecularProtein MultimerizationProtein PrenylationFarnesyltranstransferaseGGPPSmultiple myelomaoligomerizationstructure–function

Identifiers

PMID40621901
PMCPMC12591569

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.